Robin Lovell-Badge, developmental biologist and geneticist, talks to FT science columnist Anjana Ahuja about the gene-edited babies controversy in China and about the potential for new gene-editing techniques to transform the treatment of diseases like cancer and muscular dystrophy.

A transcript for this podcast is currently unavailable, view our accessibility guide.

Get alerts on Tech Tonic when a new story is published

Copyright The Financial Times Limited 2021. All rights reserved.
Reuse this content (opens in new window)

Comments have not been enabled for this podcast.

Follow the topics in this podcast